Does sleep-disordered breathing cause insulin resistance and hypertension?

Sleep-disordered breathing (SDB) is a robust clinical driver of metabolic and cardiovascular dysfunction, particularly in aging populations. The association between SDB, insulin resistance, and hypertension is well-supported by both epidemiological data and mechanistic research.

Clinical and metabolic evidence

Evidence from randomized controlled trials and meta-analyses demonstrates that SDB significantly increases the risk of metabolic syndrome. For example, studies using continuous positive airway pressure (CPAP) therapy have shown improvements in the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), with mean reductions in insulin resistance markers often observed in non-diabetic cohorts. Furthermore, longitudinal data indicate that SDB symptoms are independent predictors of incident type 2 diabetes and resistant hypertension.

Mechanistic explanations

The pathophysiology centers on two primary stressors: intermittent hypoxia and sleep fragmentation.

• Sympathetic Overdrive: Intermittent hypoxia triggers carotid body chemoreflex hyperactivity, specifically through the Olfr78-Adcy3-cAMP molecular pathway. This leads to a sustained increase in sympathetic nervous system (SNS) outflow.
• HPA Axis Activation: Sleep fragmentation and hypoxia disrupt the hypothalamic-pituitary-adrenal (HPA) axis, resulting in elevated nocturnal and early-morning cortisol levels.
• Impaired Glucose Metabolism: Elevated catecholamines (from SNS activation) and cortisol act as counter-regulatory hormones. They stimulate hepatic gluconeogenesis and inhibit insulin-stimulated glucose uptake in skeletal muscle, directly impairing glucose tolerance.

Clinical implications for older adults

In patients approximately 74 years of age, the cumulative effects of sympathetic activation may be more pronounced due to age-related changes in vascular compliance and baseline insulin sensitivity. Managing SDB is critical in this demographic to mitigate the "feed-forward" loop where insulin resistance further exacerbates hypertensive states.

Bottom line

The claim is strongly supported. Intermittent hypoxia and sleep fragmentation are the primary drivers of sympathetic and HPA axis overactivity, which directly cause insulin resistance and hypertension through impaired glucose regulation and increased vascular tone.